Abstract
Patients with rheumatoid arthritis are at higher risk for serious infections and death from infection than the general public. Prednisone and biologic agents increase this risk, although the risk associated with biologics can be mitigated when such agents act as prednisone-sparing therapies. Some of the important causes of infectious morbidity in this setting are preventable with screening (eg, tuberculosis) or vaccination (eg, herpes zoster).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 727-745 |
| Number of pages | 19 |
| Journal | Rheumatic Disease Clinics of North America |
| Volume | 38 |
| Issue number | 4 |
| DOIs | |
| State | Published - Nov 2012 |
Keywords
- Biologic therapy
- Infection prevention
- Infection risk
- Infections
- Rheumatoid arthritis
- Screening
ASJC Scopus subject areas
- Rheumatology